ETF SERIES SOLUTIONS LONCAR CANCER IMMUNOTHERAPY ETF

CNCR NASDAQ

MarketTrendDotCom

Look for confirmation. On strong uptrend = lookout for stopout. At double major support. Look to either break through and rocket higher or take a hard fall.

abdullamg

Looks like CNCR is heading to ATH of 31.70 after moving sideways for months. Let me know your thoughts

TotalBitcoinInternational

This is CNCR Loncar Cancer Immunotherapy ETF, it is trading +25% year to date, some of its 30 holdings are ATRA, IOVA, NKTR, JNCE, BGNE, ACEN, 64% in Micro Cap, last price $30.60, expense ratio 0.79%. We are bullish on it and you could too.